Background: Constipation is a common problem in gastroenterological practice. The prevalence of constipation is about 16%. Constipation can be primary or secondary. Summary: The diagnostic and therapeutic approach to patients with constipation begins with a detailed history and physical examination. In selected cases, the use of additional diagnostic procedures is very important. This includes the use of laboratory, endoscopic, and radiological examinations, as well as advanced physiological testing (anorectal manometry, balloon expulsion test, colonic transit studies, and defecography). Constipation therapy can be both nonoperative and operative. Nonoperative therapy includes the application of a lifestyle measures, pharmacotherapy and biofeedback therapy. Key Messages: Two key things when taking a medical history and physical examination are to rule out the existence of alarm symptoms/signs and to rule out secondary constipation (primarily drug-induced). Therapy begins with lifestyle modification, and in case of failure, bulk or osmotic laxatives are used. In case of failure, the use of lubiprostone is indicated, as well as linaclotide. Surgical treatment of constipation is reserved for cases of refractory constipation, with delayed intestinal transit.

1.
Forootan
M
,
Bagheri
N
,
Darvishi
M
.
Chronic constipation: a review of literature
.
Medicine
.
2018 May
;
97
(
20
):
e10631
. .
2.
Mearin
F
,
Ciriza
C
,
Mínguez
M
,
Rey
E
,
Mascort
JJ
,
Peña
E
,
Clinical practice guideline: irritable bowel syndrome with constipation and functional constipation in the adult
.
Rev Esp Enferm Dig
.
2016 Jun
;
108
(
6
):
332
63
. .
3.
Mearin
F
,
Lacy
BE
,
Chang
L
,
Chey
WD
,
Lembo
AJ
,
Simren
M
,
Bowel disorders
.
Gastroenterology
.
2016 Feb 18
. .
4.
Ghoshal
UC
,
Sachdeva
S
,
Pratap
N
,
Verma
A
,
Karyampudi
A
,
Misra
A
,
Indian consensus on chronic constipation in adults: a joint position statement of the Indian Motility and Functional Diseases Association and the Indian Society of gastroenterology
.
Indian J Gastroenterol
.
2018 Nov
;
37
(
6
):
526
44
. .
5.
Lindberg
G
,
Hamid
SS
,
Malfertheiner
P
,
Thomsen
OO
,
Fernandez
LB
,
Garisch
J
,
World Gastroenterology Organisation global guideline: constipation: a global perspective
.
J Clin Gastroenterol
.
2011 Jul
;
45
(
6
):
483
7
.
6.
Fang
X
,
Francisconi
CF
,
Fukudo
S
,
Gerson
MJ
,
Kang
JY
,
Schmulson W
MJ
,
Multicultural aspects in functional gastrointestinal disorders (FGIDs)
.
Gastroenterology
.
2016 Feb 15
. .
7.
Hsieh
C
.
Treatment of constipation in older adults
.
Am Fam Physician
.
2005 Dec 1
;
72
(
11
):
2277
84
.
8.
Drossman
DA
.
The functional gastrointestinal disorders and the Rome III process
.
Gastroenterology
.
2006 Apr
;
130
(
5
):
1377
90
. .
9.
Paquette
IM
,
Varma
M
,
Ternent
C
,
Melton-Meaux
G
,
Rafferty
JF
,
Feingold
D
,
The American Society of Colon and rectal surgeons’ clinical practice guideline for the evaluation and management of constipation
.
Dis Colon Rectum
.
2016 Jun
;
59
(
6
):
479
92
. .
10.
Brandt
LJ
,
Prather
CM
,
Quigley
EM
,
Schiller
LR
,
Schoenfeld
P
,
Talley
NJ
.
Systematic review on the management of chronic constipation in North America
.
Am J Gastroenterol
.
2005
;
100
(
Suppl 1
):
S5
21
. .
11.
Rao
SS
.
Advances in diagnostic assessment of fecal incontinence and dyssynergic defecation
.
Clin Gastroenterol Hepatol
.
2010 Nov
;
8
(
11
):
910
9
. .
12.
Tantiphlachiva
K
,
Rao
P
,
Attaluri
A
,
Rao
SS
.
Digital rectal examination is a useful tool for identifying patients with dyssynergia
.
Clin Gastroenterol Hepatol
.
2010 Nov
;
8
(
11
):
955
60
. .
13.
Rao
SS
,
Meduri
K
.
What is necessary to diagnose constipation?
Best Pract Res Clin Gastroenterol
.
2011 Feb
;
25
(
1
):
127
40
. .
14.
Minguez
M
,
Herreros
B
,
Sanchiz
V
,
Hernandez
V
,
Almela
P
,
Añon
R
,
Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation
.
Gastroenterology
.
2004 Jan
;
126
(
1
):
57
62
. .
15.
Vork
L
,
van Avesaat
MHP
,
van Hoboken
EA
,
Kruimel
JW
,
Conchillo
JM
,
Keszthelyi
D
,
Normal colonic transit time predicts the outcome of colonic manometry in patients with chronic constipation-an exploratory study
.
Int J Colorectal Dis
.
2019 Oct
;
34
(
10
):
1819
22
. .
16.
Kim
NY
,
Kim
DH
,
Pickhardt
PJ
,
Carchman
EH
,
Wald
A
,
Robbins
JB
.
Defecography: an overview of technique, interpretation, and impact on patient care
.
Gastroenterol Clin North Am
.
2018 Sep
;
47
(
3
):
553
68
. .
17.
Serra
J
,
Mascort-Roca
J
,
Marzo-Castillejo
M
,
Aros
SD
,
Ferrándiz Santos
J
,
Rey Diaz Rubio
E
,
Clinical practice guidelines for the management of constipation in adults. Part 2: diagnosis and treatment
.
Gastroenterol Hepatol
.
2017 Apr
;
40
(
4
):
303
16
. .
18.
Suares
NC
,
Ford
AC
.
Systematic review: the effects of fibre in the management of chronic idiopathic constipation
.
Aliment Pharmacol Ther
.
2011 Apr
;
33
(
8
):
895
901
. .
19.
Popovic
D
,
Spuran
M
,
Jovanović
I
.
Plantago ovata u terapiji hronične opstipacije-rezultati multicentrične studije
.
Arch Gastroenterohepatol
.
2012 Mar
;
29
(
1
):
35
41
.
20.
Hammer
HF
,
Santa Ana
CA
,
Schiller
LR
,
Fordtran
JS
.
Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose
.
J Clin Invest
.
1989 Oct
;
84
(
4
):
1056
62
. .
21.
Fritz
E
,
Hammer
HF
,
Lipp
RW
,
Högenauer
C
,
Stauber
R
,
Hammer
J
.
Effects of lactulose and polyethylene glycol on colonic transit
.
Aliment Pharmacol Ther
.
2005 Feb 1
;
21
(
3
):
259
68
. .
22.
Schey
R
,
Rao
SS
.
Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome
.
Dig Dis Sci
.
2011 Jun
;
56
(
6
):
1619
25
. .
23.
Lembo
A
.
Constipation
. In:
Feldman
M
,
Friedman
L
,
Brandt
L
, editors.
Sleisenger and Fordtran’s gastrointestinal and liver disease
. 10th ed.
Philadelphia, PA
:
Elsevier Saunders
;
2016
. p.
270
94
.
24.
Li
F
,
Fu
T
,
Tong
WD
,
Liu
BH
,
Li
CX
,
Gao
Y
,
Lubiprostone is effective in the treatment of chronic idiopathic constipation and irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials
.
Mayo Clin Proc
.
2016 Apr
;
91
(
4
):
456
68
. .
25.
Corsetti
M
,
Tack
J
.
Linaclotide: a new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation
.
United European Gastroenterol J
.
2013 Feb
;
1
(
1
):
7
20
. .
26.
Layer
P
,
Stanghellini
V
.
Review article: Linaclotide for the management of irritable bowel syndrome with constipation
.
Aliment Pharmacol Ther
.
2014 Feb
;
39
(
4
):
371
84
. .
27.
Bassotti
G
,
Usai-Satta
P
,
Bellini
M
.
Linaclotide for the treatment of chronic constipation
.
Expert Opin Pharmacother
.
2018 Aug
;
19
(
11
):
1261
6
. .
28.
Bassotti
G
,
Usai Satta
P
,
Bellini
M
.
Plecanatide for the treatment of chronic idiopathic constipation in adult patients
.
Expert Rev Clin Pharmacol
.
2019 Nov
;
12
(
11
):
1019
26
. .
29.
Bassotti
G
,
Usai Satta
P
,
Bellini
M
.
Prucalopride for the treatment of constipation: a view from 2015 and beyond
.
Expert Rev Gastroenterol Hepatol
.
2019 Mar
;
13
(
3
):
257
62
. .
30.
Garnock-Jones
KP
,
McKeage
K
.
Methylnaltrexone
.
Drugs
.
2010 May 7
;
70
(
7
):
919
28
. .
31.
Thomas
J
,
Karver
S
,
Cooney
GA
,
Chamberlain
BH
,
Watt
CK
,
Slatkin
NE
,
Methylnaltrexone for opioid-induced constipation in advanced illness
.
N Engl J Med
.
2008 May 29
;
358
(
22
):
2332
43
. .
32.
Andresen
V
,
Layer
P
.
Medical therapy of constipation: current standards and beyond
.
Visc Med
.
2018 Apr
;
34
(
2
):
123
7
. .
33.
Serra
J
,
Pohl
D
,
Azpiroz
F
,
Chiarioni
G
,
Ducrotté
P
,
Gourcerol
G
,
European society of neurogastroenterology and motility guidelines on functional constipation in adults
.
Neurogastroenterol Motil
.
2020 Feb
;
32
(
2
):
e13762
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.